Skip to content
DataLookout
Menu

NCT06625749

Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 1 year 8 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Mar 2026 to Dec 2027
    • Eligibility criteria expanded, about 61 words
    • Primary endpoints: details revised at 1 of 1 entry
    • Trial status changed: Unknown → Recruiting
  2. Minor Changed Registry marked status Unknown; last known: Recruiting
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Improvement in uncorrected near visual acuity (UCNVA) at 40 cm/16 inches
Timeframe: 12 months

Arms and interventions

AccuraSee™ intraocular pseudophakic capsular lens (IOPCL)Experimental

Devices: Accurasee™ IOPCL

Sites

1 site in 1 country

  • Midwest Vision PartnersCleveland, Ohio, United States